Serum neuron-specific enolase as early predictor of outcome after in-hospital cardiac arrest : a cohort study
AUTOR(ES)
Rech, Tatiana Helena
DATA DE PUBLICAÇÃO
2010
RESUMO
Introduction Outcome after cardiac arrest is mostly determined by the degree of hypoxic brain damage. Patients recovering from cardiopulmonary resuscitation are at great risk of subsequent death or severe neurological damage, including persistent vegetative state. The early definition of prognosis for these patients has ethical and economic implications. The main purpose of this study was to investigate the prognostic value of serum neuron-specific enolase (NSE) in predicting outcomes in patients early after in-hospital cardiac arrest. Methods Forty-five patients resuscitated from in-hospital cardiac arrest were prospectively studied from June 2003 to January 2005. Blood samples were collected, at any time between 12 and 36 hours after the arrest, for NSE measurement. Outcome was evaluated 6 months later with the Glasgow outcome scale (GOS). Patients were divided into two groups: group 1 (unfavorable outcome) included GOS 1 and 2 patients; group 2 (favorable outcome) included GOS 3, 4 and 5 patients. The Mann–Whitney U test, Student's t test and Fisher's exact test were used to compare the groups. Results The Glasgow coma scale scores were 6.1 ± 3 in group 1 and 12.1 ± 3 in group 2 (means ± SD; p < 0.001). The mean time to NSE sampling was 20.2 ± 8.3 hours in group 1 and 28.4 ± 8.7 hours in group 2 (p = 0.013). Two patients were excluded from the analysis because of sample hemolysis. At 6 months, favorable outcome was observed in nine patients (19.6%). Thirty patients (69.8%) died and four (9.3%) remained in a persistent vegetative state. The 34 patients (81.4%) in group 1 had significantly higher NSE levels (median 44.24 ng/ml, range 8.1 to 370) than those in group 2 (25.26 ng/ml, range 9.28 to 55.41; p = 0.034). Conclusion Early determination of serum NSE levels is a valuable ancillary method for assessing outcome after inhospital cardiac arrest.
ASSUNTO(S)
parada cardíaca marcadores biológicos fosfopiruvato hidratase pacientes internados estudos de coortes prognóstico
ACESSO AO ARTIGO
http://hdl.handle.net/10183/21533Documentos Relacionados
- Prediction of cognitive dysfunction after resuscitation from out‐of‐hospital cardiac arrest using serum neuron‐specific enolase and protein S‐100
- Valor da enolase específica do neurônio como indicador de prognóstico pós-parada cardiorrespiratória
- Use of neuron-specific enolase for assessing the severity and outcome of neurological disorders in patients
- Neuron-specific enolase as biomarker for possible neuronal damage in dogs with distemper vírus
- In-hospital audit underestimates early postoperative morbidity after cardiac surgery.